DE69917663D1 - 2-methyl-thieno-benzodiazepin-formulierung - Google Patents

2-methyl-thieno-benzodiazepin-formulierung

Info

Publication number
DE69917663D1
DE69917663D1 DE69917663T DE69917663T DE69917663D1 DE 69917663 D1 DE69917663 D1 DE 69917663D1 DE 69917663 T DE69917663 T DE 69917663T DE 69917663 T DE69917663 T DE 69917663T DE 69917663 D1 DE69917663 D1 DE 69917663D1
Authority
DE
Germany
Prior art keywords
thieno
methyl
benzodiazepine formulation
formulation
olanzapine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69917663T
Other languages
English (en)
Other versions
DE69917663T2 (de
Inventor
Arthur Bunnell
Harry Ferguson
Barry Arnold Hendriksen
Manuel Vicente Sanchez-Felix
David Edward Tupper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/163,769 external-priority patent/US6169084B1/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE69917663D1 publication Critical patent/DE69917663D1/de
Application granted granted Critical
Publication of DE69917663T2 publication Critical patent/DE69917663T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69917663T 1998-09-30 1999-03-24 2-methyl-thieno-benzodiazepin-formulierung Expired - Lifetime DE69917663T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16376898A 1998-09-30 1998-09-30
US163768 1998-09-30
US09/163,769 US6169084B1 (en) 1997-09-30 1998-09-30 2-methyl-thieno-benzodiazepine formulation
US163769 1998-09-30
PCT/US1999/006417 WO2000018408A1 (en) 1998-09-30 1999-03-24 2-methyl-thieno-benzodiazepine formulation

Publications (2)

Publication Number Publication Date
DE69917663D1 true DE69917663D1 (de) 2004-07-01
DE69917663T2 DE69917663T2 (de) 2005-05-25

Family

ID=26859927

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69917663T Expired - Lifetime DE69917663T2 (de) 1998-09-30 1999-03-24 2-methyl-thieno-benzodiazepin-formulierung
DE69935873T Expired - Lifetime DE69935873T2 (de) 1998-09-30 1999-03-24 2-Methyl-thieno-benzodiazepin Formulierung

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69935873T Expired - Lifetime DE69935873T2 (de) 1998-09-30 1999-03-24 2-Methyl-thieno-benzodiazepin Formulierung

Country Status (28)

Country Link
EP (1) EP1119359B1 (de)
JP (1) JP4551988B2 (de)
CN (1) CN1146422C (de)
AT (2) ATE267602T1 (de)
AU (1) AU759751B2 (de)
BR (1) BR9914156A (de)
CA (1) CA2344873A1 (de)
CZ (1) CZ302367B6 (de)
DE (2) DE69917663T2 (de)
DK (2) DK1468689T3 (de)
EA (1) EA002580B1 (de)
ES (2) ES2221376T3 (de)
GE (1) GEP20094818B (de)
HK (1) HK1041199B (de)
HR (1) HRP20010238B1 (de)
HU (1) HU227400B1 (de)
ID (1) ID29574A (de)
IL (2) IL141766A0 (de)
MY (1) MY126476A (de)
NO (1) NO328243B1 (de)
NZ (1) NZ510208A (de)
PL (1) PL196821B1 (de)
PT (2) PT1468689E (de)
SK (1) SK285944B6 (de)
TR (1) TR200100885T2 (de)
TW (1) TW577890B (de)
UA (1) UA66872C2 (de)
WO (1) WO2000018408A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001047933A1 (en) * 1999-12-28 2001-07-05 Cipla Limited New polymorphic forms of olanzapine
US7022698B2 (en) 1999-12-28 2006-04-04 U & I Pharmaceuticals, Ltd. Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof
PL196814B1 (pl) 2002-05-17 2008-02-29 Inst Farmaceutyczny Sposób wytwarzania odmiany polimorficznej I olanzapiny i jej solwaty
HU226410B1 (en) * 2003-04-22 2008-11-28 Egis Gyogyszergyar Nyilvanosan Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
DE05783995T1 (de) * 2004-07-14 2007-10-11 Shasun Chemicals and Drugs Ltd., Chennai Verbessertes verfahren zur herstellung von form i aus olanzapin
ES2253091B1 (es) * 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
US20090155331A1 (en) * 2005-11-16 2009-06-18 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
EP2623095A1 (de) * 2004-11-16 2013-08-07 Elan Pharma International Limited Injizierbare Olanzapin-Formulierungen in Nanoteilchenform
ATE511512T1 (de) * 2005-01-05 2011-06-15 Lilly Co Eli Olanzapinpamoat-dihydrat
CZ2006697A3 (cs) * 2006-11-07 2008-05-21 Zentiva, A. S. Kompozice depotních olanzapinových injekcních systému
FR2927965B1 (fr) * 2008-02-22 2010-06-04 Valeo Materiaux De Friction Sa Procede de fabrication d'un materiau de friction et notamment d'une couronne de friction d'embrayage.
RU2548753C2 (ru) * 2009-11-16 2015-04-20 Ипсен Фарма С.А.С. Фармацевтические композиции лигандов рецепторов меланокортинов
WO2011091142A2 (en) * 2010-01-20 2011-07-28 Teva Pharmaceutical Industries Ltd. Crystalline and amorphous forms of olanzapine pamoate
CA2814840C (en) 2010-10-18 2018-08-28 Dainippon Sumitomo Pharma Co., Ltd. Sustained-release formulation for injection
EP2956456B1 (de) 2013-02-13 2017-07-12 Neuland Laboratories Ltd Verfahren zur herstellung von olanzapinpamoat
CN105044231B (zh) * 2015-06-27 2022-09-13 万特制药(海南)有限公司 一种分离测定奥氮平双羟萘酸盐一水合物有关物质的方法
EP3600258A1 (de) * 2017-03-20 2020-02-05 Teva Pharmaceuticals International GmbH Olanzapinformulierungen mit verzögerter freisetzung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2095499A1 (en) * 1992-05-08 1993-11-09 Petrus J. M. Van Den Oetelaar Depot preparation
PT669128E (pt) * 1992-11-17 2000-06-30 Yoshitomi Pharmaceutical Micro-esfera de libertacao sustentada contendo antipsicoticos e processo para produzir a mesma
TW376319B (en) * 1993-04-28 1999-12-11 Janssen Pharmaceutica Nv Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5891461A (en) * 1995-09-14 1999-04-06 Cygnus, Inc. Transdermal administration of olanzapine
RS49597B (sr) * 1996-09-23 2007-06-04 Eli Lilly And Company, Olanzapin dihidrat d
UA73715C2 (en) * 1997-09-30 2005-09-15 Lilly Co Eli Pharmaceutically acceptable formulation of olanzapine pamoate and its use for treatment

Also Published As

Publication number Publication date
NO20011583D0 (no) 2001-03-28
DK1468689T3 (da) 2007-08-13
HRP20010238A2 (en) 2002-04-30
BR9914156A (pt) 2001-06-26
DE69935873D1 (de) 2007-05-31
DE69917663T2 (de) 2005-05-25
IL141766A (en) 2006-12-31
HUP0103636A3 (en) 2003-05-28
ES2285294T3 (es) 2007-11-16
IL141766A0 (en) 2002-03-10
EP1119359A4 (de) 2001-12-19
WO2000018408A1 (en) 2000-04-06
CN1320038A (zh) 2001-10-31
JP2002525330A (ja) 2002-08-13
CN1146422C (zh) 2004-04-21
NZ510208A (en) 2003-04-29
PL196821B1 (pl) 2008-02-29
HK1041199B (zh) 2005-03-18
SK285944B6 (sk) 2007-11-02
PT1468689E (pt) 2007-07-09
TW577890B (en) 2004-03-01
NO20011583L (no) 2001-03-28
SK4162001A3 (en) 2002-03-05
DE69935873T2 (de) 2008-01-10
TR200100885T2 (tr) 2001-08-21
EA200100406A1 (ru) 2001-10-22
EA002580B1 (ru) 2002-06-27
HUP0103636A2 (hu) 2002-01-28
MY126476A (en) 2006-10-31
PT1119359E (pt) 2004-08-31
ATE359793T1 (de) 2007-05-15
HK1041199A1 (en) 2002-07-05
UA66872C2 (uk) 2004-06-15
ES2221376T3 (es) 2004-12-16
PL346981A1 (en) 2002-03-11
CA2344873A1 (en) 2000-04-06
CZ20011149A3 (cs) 2002-01-16
NO328243B1 (no) 2010-01-11
CZ302367B6 (cs) 2011-04-13
EP1119359A1 (de) 2001-08-01
ID29574A (id) 2001-09-06
GEP20094818B (en) 2009-11-10
ATE267602T1 (de) 2004-06-15
AU3362799A (en) 2000-04-17
JP4551988B2 (ja) 2010-09-29
DK1119359T3 (da) 2004-08-16
AU759751B2 (en) 2003-05-01
EP1119359B1 (de) 2004-05-26
HU227400B1 (en) 2011-05-30
HRP20010238B1 (en) 2006-05-31

Similar Documents

Publication Publication Date Title
TR200000812T2 (tr) 2-metil-tieno- benzodiazepin formülasyonu.
DE69917663D1 (de) 2-methyl-thieno-benzodiazepin-formulierung
ES2180899T3 (es) Dihidrato d de olanzapina.
NO20010556L (no) Fremgangsmate for oftalmisk administrering
EA199900373A2 (ru) Фармацевтические композиции
TR199800759T2 (xx) Protein Kinaz C �nhibit�r�.
YU15299A (sh) Farmaceutski sastavi
DE69730488D1 (de) Bipolare Hüftgelenkpfanne
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
NL1006065A1 (nl) Inlegkruisje voor stringslip.
EP1073447A4 (de) N1 modifizierte glycopeptide
UY26574A1 (es) " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
HUP9802500A3 (en) Pocess for the preparation of periodates
ECSP992901A (es) Formulacion de 2- metil -tieno benzodiazepina
ECSP972052A (es) Quinoxalinadionas
ITMI982242A0 (it) Procedimento per la preparazione di un derivato dell'isobenzofurano
IT239834Y1 (it) Tappo per scarichi di apparecchi sanitari.
ES2196503T3 (es) Procedimientos e intermedios para la preparacion de pirrolo(3,2-b)piridinas.
UA25365A (uk) Спосіб профілактики вториhhої катаракти
IT1282956B1 (it) Procedimento per la preparazione di un azetidinone
ITBO970374A3 (it) Presidio igienico per apparecchi sanitari.
IT239670Y1 (it) Idro-contenitore per l'innalzamento provvisorio di argini.
ITLT940001V0 (it) Pareggiatore ortopedico per invalidi temporanei.
JO1909B1 (en) Composition of 2-methylthenio-benzodiazepine oral

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN